Skip to nav Skip to content

Reimbursement and compensation policy

Fair and adequate reimbursement for infectious diseases physicians is a key IDSA policy priority. In the public policy arena, the Society promotes the value of ID physicians and supports access to and appropriate reimbursement for infectious diseases services. IDSA also supports funding and policies that foster ID training. The Society also advocates for access to appropriate treatments for patients with serious infections. IDSA’s positions on specific reimbursement and compensation issues that impact the practice of infectious diseases and advocacy alerts to key policy priorities are provided below. 

 

 

 

Key policy priorities

  • In early November, CMS released the CY 2025 Outpatient Prospective Payment System Final Rule. A positive development in the Final Rule was that the OPPS conversion factor was increased by 2.6%. Additionally, CMS finalized its proposals for payment of HIV PrEP drugs and related services under the OPPS as preventive services in accordance with the final national coverage determination effective Sept. 30, 2024.

  • In early November, CMS released the CY 2025 Medicare Physician Fee Schedule Final Rule. Thanks to ongoing advocacy from IDSA members, CMS included a new add-on code for ID developed and advocated for by IDSA that was included in the MPFS Final Rule.

  • IDSA President Steven Schmitt, MD, FIDSA, submitted a letter to the Senate Finance Committee leadership in response to their white paper on Medicare physician payment. In the letter, IDSA urged Congress to include ID physician incentives in upcoming payment model changes.

Contact your congressional representative through our Advocacy Center to show your support for the development of new and rapid diagnostic tests for infectious diseases.

Advertisement

2024-2025

 

 

2025

  • 4/11/2025 IDSA submitted comments ahead of the ACIP meeting in April 2025 highlighting key ID topics.

  • The addition of HCPCS code G0545, which recognizes the complexity of ID care, has further strengthened efforts to expand access to ID services.

  • Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Prescription Drug Inflation Rebate Program; and Medicare Overpayments

2024

Related websites

Medicare Evidence Development & Coverage Advisory Committee

Medicare Payment Advisory Commission

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.